Inflammatory bowel disease (IBD) describes a collection of conditions affecting the digestive tract. Inflammatory bowel disease is a result of immunologic imbalances at the interface of the intestinal lumen and the intestinal epithelium. Suppressing inflammation is the chief goal of both conventional and integrative treatment to improve and rectify this condition. On the other hand, several natural interventions such as omega-3 fatty acids, vitamin D, and probiotics modulate immune cell function without impairing infection-fighting ability.
Unfortunately, patients with IBD are predisposed to colon cancer. Even between disease flares, low-level inflammation irritates and damages intestinal tissue, which can lead to malignancy. Therefore, not only is it imperative that patients with inflammatory bowel disease have regular colon cancer screenings, but also that they monitor inflammatory markers in their blood.